Please Wait...

Independent, Centralized Image Review and Analyses Supporting Development of VK2809 to Treat NAFLD/NASH

Non-alcoholic fatty liver disease (NAFLD), and its progression to non-alcoholic steatohepatitis (NASH), is estimated to become the most common chronic liver condition in Western populations. However, the etiology of NAFLD/NASH is not well understood, and, despite many Phase III trials, a drug has not yet been approved for treatment. Therefore, ongoing research is essential. Clinical medical imaging can be an effective tool to appropriately confirm patient eligibility and monitor treatment efficacy in NAFLD/NASH drug development. Further, independent central review and analyses of medical images can ensure high-quality results throughout the duration of the trial.

Download our case study to learn how advanced medical imaging played an important role during the clinical trial conducted by Viking Therapeutics to evaluate VK2809 for the treatment of patients with biopsy-proven NASH with fibrosis.

 

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Read our CEO’s thoughts on Bioclinica’s mission-driven growth agenda. https://t.co/d3OGmHAhK0 #bioclinica… https://t.co/0c2iqAAol6
Bioclinica (22 hours ago)
Changes are a fact of life - and of #clinicaltrial design. But that doesn't mean planning and budgeting for your tr… https://t.co/BUPFjuIXOt
Bioclinica (3 days ago)
Bioclinica announced today that the company has contributed data to the primary efficacy endpoint in more than 200… https://t.co/8epFHqKFcL
Bioclinica (2 weeks ago)
No change order fees for new clients with our #RTSM platform means fewer hurdles as you race to study start. Ready… https://t.co/Z5AOtkWT3e
Bioclinica (2 weeks ago)
With over 25 years of experience in Cardiac Safety monitoring services, Bioclinica is a recognized global leader in… https://t.co/CMY48C4QVR
Bioclinica (3 weeks ago)
Bioclinica is an agile organization with more 2,300 colleagues around the globe - and growing! Learn more here.… https://t.co/oLPRURkhm7
Bioclinica (3 weeks ago)